Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,861 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.
Levine RL, Loriaux M, Huntly BJ, Loh ML, Beran M, Stoffregen E, Berger R, Clark JJ, Willis SG, Nguyen KT, Flores NJ, Estey E, Gattermann N, Armstrong S, Look AT, Griffin JD, Bernard OA, Heinrich MC, Gilliland DG, Druker B, Deininger MW. Levine RL, et al. Among authors: berger r. Blood. 2005 Nov 15;106(10):3377-9. doi: 10.1182/blood-2005-05-1898. Epub 2005 Aug 4. Blood. 2005. PMID: 16081687 Free PMC article. Clinical Trial.
Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.
Malinge S, Ben-Abdelali R, Settegrana C, Radford-Weiss I, Debre M, Beldjord K, Macintyre EA, Villeval JL, Vainchenker W, Berger R, Bernard OA, Delabesse E, Penard-Lacronique V. Malinge S, et al. Among authors: berger r. Blood. 2007 Mar 1;109(5):2202-4. doi: 10.1182/blood-2006-09-045963. Epub 2006 Oct 26. Blood. 2007. PMID: 17068151 Free article.
t(8;21) prior to acute leukemia.
Berger R, Hillion J, Janvier D, Chen Z, Bussel A. Berger R, et al. Cancer Genet Cytogenet. 1993 Oct 15;70(2):125-6. doi: 10.1016/0165-4608(93)90181-k. Cancer Genet Cytogenet. 1993. PMID: 8242592
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffé M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA. Lacronique V, et al. Among authors: berger r. Blood. 2000 Mar 15;95(6):2076-83. Blood. 2000. PMID: 10706877 Free article.
3,861 results